Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database
Clinical trial NCT07079644 · COMPLETED
Trial details
- NCT number
- NCT07079644
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-29
- Primary completion
- 2025-03-31
- Enrollment
- 678
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.